In vitro synergistic activity of combined piperacillin and tobramycin against clinical strains of Achromobacter xylosoxidans.
Duez
J-M
JM
Laboratoire de Bactériologie Médicale, CHU de Dijon, France. jean-marie.duez@chu-dijon.fr
Hadjait-Savioz
M
M
Siebor
E
E
Astruc
K
K
Bador
J
J
Péchinot
A
A
Sixt
N
N
Huet
F
F
Neuwirth
C
C
D042441:Achromobacter denitrificans / Q000187:drug effects* / Q000302:isolation & purification; D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial; D004357:Drug Synergism; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D010878:Piperacillin / Q000494:pharmacology*; D014031:Tobramycin / Q000494:pharmacology*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D014031:Tobramycin; D010878:Piperacillin